ivWatch said today that it won CE Mark clearance for its intravenous infiltration/extravasation monitoring device.
The company’s ivWatch Model 400, which has FDA clearance, is sold in the U.S. through group purchasing contracts with Premier and Vizient.
Get the full story at our sister site, Drug Delivery Business News.
The post ivWatch wins CE Mark for continuous IV site monitor appeared first on MassDevice.